Normal QuantiFERON-TB Gold Plus TB1 Antigen Value
A QuantiFERON-TB Gold Plus test is considered negative (normal) when the TB1 antigen tube interferon-γ concentration is less than 0.35 IU/mL (after subtracting the Nil control value).
Interpretation Criteria
The interpretation of QuantiFERON-TB Gold Plus follows established FDA-approved criteria that apply to both TB1 and TB2 antigen tubes 1:
Negative Result (Normal)
- TB Response (TB antigen minus Nil) < 0.35 IU/mL
- This indicates no evidence of Mycobacterium tuberculosis infection
Positive Result
- TB Response ≥ 0.35 IU/mL AND
- TB Response ≥ 25% of the Nil control value (when Nil is 0.7-8.0 IU/mL)
Indeterminate Result
- Mitogen control (positive control) ≤ 0.5 IU/mL (inadequate immune response), OR
- Nil control > 8.0 IU/mL (excessive background)
Important Clinical Considerations
The Borderline Zone
While the official cutoff is 0.35 IU/mL, values between 0.20-0.99 IU/mL represent a clinically important "borderline zone" where test variability is highest 2, 3. Recent evidence shows:
- 38.3% of borderline results (0.20-0.34 IU/mL) revert to convincingly negative (<0.20 IU/mL) on repeat testing without any cases of active TB developing within 2 years 2
- False-positive results occur particularly in the 0.35-1.0 IU/mL range, especially with healthcare worker screening 3
- Consider repeat testing for values between 0.35-1.0 IU/mL before committing patients to tuberculosis preventive therapy, particularly in low-risk populations
TB1 vs TB2 Tubes
The QuantiFERON-TB Gold Plus includes two antigen tubes:
- TB1: Contains peptides from ESAT-6 and CFP-10 (primarily CD4+ T-cell response)
- TB2: Contains shorter peptides from CFP-10 designed to elicit CD8+ T-cell response 1
The test is positive if EITHER TB1 OR TB2 meets positive criteria. However, TB2 contributes minimally to diagnosis—only 0.4% of tests show TB2 ≥0.35 IU/mL with TB1 <0.20 IU/mL 2.
Common Pitfalls to Avoid
Automated analyzer inflation: The Liaison XL chemiluminescence analyzer produces systematically higher values than ELISA, with a bias of +0.21 IU/mL 4. This can convert borderline-negative results to false-positives. Consider confirming borderline-positive CLIA results (0.35-1.3 IU/mL) with ELISA, which reduces false-positives by 84.3% 4.
High Nil values: When the Nil control is elevated (>0.7 IU/mL but <8.0 IU/mL), the TB Response must be both ≥0.35 IU/mL AND ≥25% greater than the Nil value to be considered positive 1.
Low-risk populations: In settings with low TB prevalence, positive results <1.0 IU/mL have higher false-positive rates and warrant clinical correlation or repeat testing 3.
Cannot distinguish recent from remote infection: Despite TB2 tube marketing, TB2-TB1 differences >0.6 IU/mL do NOT reliably identify recent TB exposure and should not be used for contact tracing decisions 5.
Clinical Context
Negative results alone cannot exclude TB infection in high-risk individuals (HIV-positive, children <5 years, immunosuppressed patients, or those with clinical/radiographic findings suggestive of active TB) 6. In these populations, a negative test should not prevent further evaluation or treatment if clinical suspicion remains high.